HCP Live

Rheumatoid Arthritis Quiz: Effectiveness of COVID-19 Vaccines in Patients With RA

Apr 11, 2022

Ingrid Torjesen

At the outset of the COVID-19 pandemic, there were concerns that patients with rheumatoid arthritis would be more vulnerable due to their condition and its treatment. What impact has the availability of vaccines against COVID-19 had on the vulnerability of patients with rheumatoid arthritis? Test your knowledge with this quiz.

What changes to disease activity can RA patients expect immediately post vaccination?

Related Videos

Balancing COVID-19 Risk and Wellness in Patients with Rheumatic Diseases

Exploring Patient Experiences, Challenges of Rheumatic Disease Management During the Pandemic

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Natalie McCormick, PhD | Credit: American College of Rheumatology

Brian LaMoreaux, MD | Credit: Horizon Therapeutics

Esther Ellen Freeman, MD, PhD: How COVID-19 Is Affecting Skin Differently in 2023

Megan Noe, MD, MPH: Dermatologists Join the Vaccine Discussion

Megan Noe, MD, MPH: Navigating COVID-19 Vaccines, Boosters with the Immunocompromised

Related Content

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Related Content

George Karpouzas, MD | Credit: Lundquist Institute

Analysis Offers Insight into Patients Most Likely to Derive Benefit from Tofacitinib

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Relatable Rheumatology: Making the Invisible Visible Using Patient-Reported Outcomes in Research

Shilpa Venkatachalam, PhD, MPH | Credit: Global Healthy Living Foundation

Patients With Psoriatic Arthritis Interested in Wellness Program, Although Barriers Remain

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

Introducing the Relatable Rheumatology: From Stories to Studies Podcast

Natalie McCormick, PhD | Credit: American College of Rheuamtology

SGLT2 Inhibitors Could Lower Risk of Recurrent Gout Flares in People with Diabetes

A pregnant woman having a discussion with their doctor | Credit: Mart Production - Pexels

Depressive Symptoms During Pregnancy, Postpartum Depression Common in Women with Rheumatic Disease

Do Not Sell My Information

Terms & Conditions

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.